Nonprescription/OTC.”
Similar Posts
Search for Regulatory References | Drugs
Find information on drug development, applications, submissions, manufacturing & quality, safety, labeling and moreEarly Alert: Microbore Extension Set Issue from B. Braun Medical Inc.
This communication is part of the Communications Pilot to Enhance the Medical Device Recall ProgramCompounding and the FDA: Questions and Answers
Creating a medication tailored to the needs of an individual patient. FDA answers the “what” and “why” of compounding. From consumers to health care professionals, there are many questions about compounding. FDA works to answer questions related to the meaning, intent and requirements of compoundingPatient Education
Generic medications are just as safe and effective as their brand-name counterparts, and often cost less. To help educate patients about FDA’s rigorous review process, the economics of pricing, and related issues, FDA offers a range of educational materials, including videos, graphics, fact sheets,.Human Drug Compounding Outsourcing Facility Fees
Human Drug Compounding Outsourcing Facility FeesSummary Metrics of Drug Development Tool Qualification Projects Submitted to FDA
This Table provides the current number of active CDER Drug Development Tool (DDT) Qualification projects overall and by Program (DDT- Animal Model Qualification Program, DDT- Biomarker Qualification Program, DDT- Clinical Outcomes Assessment [COA] Qualification Program). Numbers are also provided by